Nerve Block for Post-Surgery Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a specific pain treatment, the Pecto-Intercostal Fascial Block, can reduce pain after heart surgery. Participants will receive either a nerve block with the local anesthetic ropivacaine or a placebo solution, in addition to standard pain management care. Doctors will assess pain and nausea levels post-surgery to determine if the nerve block offers additional benefits. Individuals undergoing their first heart surgery through the chest bone and without chronic pain issues may be suitable for this trial. As an unphased trial, it provides participants the chance to contribute to innovative pain management research.
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, your medical history and medications taken within a month prior to surgery will be reviewed, so it's best to discuss this with the trial team.
What prior data suggests that this nerve block technique is safe for post-surgery pain management?
Research shows that the pecto-intercostal fascial block (PIFB) with ropivacaine is generally safe for managing post-surgical pain. Studies have found that this method effectively relieves pain with a low risk of serious side effects.
For instance, one study found that patients who received PIFB experienced better pain control and required fewer opioids, which are strong pain medications with potential side effects. Another study demonstrated that using PIFB in children undergoing heart surgery was safe and effective, with no major complications reported.
Overall, evidence suggests that PIFB with ropivacaine is well-tolerated and helps manage pain without causing significant problems.12345Why are researchers excited about this trial?
Most treatments for post-surgery pain rely on systemic medications like opioids or NSAIDs, which can have significant side effects. But the pecto-intercostal fascial block with ropivacaine offers a targeted approach, using a local anesthetic injected directly under ultrasound guidance. This method minimizes the need for systemic pain relievers, reducing potential side effects and enhancing pain control precisely where it's needed. Researchers are excited because this technique could lead to faster recovery times and a more comfortable post-operative experience for patients.
What evidence suggests that the Pecto-intercostal Fascial Block is effective for post-surgery pain?
Research has shown that the pecto-intercostal fascial block (PIFB) with ropivacaine, which participants in this trial may receive, effectively reduces post-surgical pain. Studies have found that it decreases the need for opioids, strong painkillers, and helps patients recover faster. Patients who received this type of block often reported better pain relief after surgeries, especially those involving the chest. This technique numbs specific nerves with ropivacaine, a local anesthetic, aiming to provide longer-lasting pain relief without heavily relying on medications like opioids.12367
Are You a Good Fit for This Trial?
This trial is for individuals undergoing open heart surgery, who can have their medical history and medication use reviewed. They must be able to receive a nerve block in addition to standard pain control methods. There's no information on who cannot participate provided here.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a bilateral nerve block with ropivacaine or saline during open-heart surgery
Postoperative Monitoring
Pain, nausea, and vomiting scores are assessed at 12, 24, and 48 hours after surgery
Follow-up
Participants are monitored for pain-DETECT scores at 30, 60, and 90 days after surgery
What Are the Treatments Tested in This Trial?
Interventions
- Pecto-intercostal Fascial Block with 20 ml of 0.35% ropivacaine
- Pecto-intercostal Fascial Block with normal saline
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor